Adalton Ribeiro

HTA Specialist Consultant at SCMED/ANVISA

São Paulo, BR

How does this work?
About

- Pharmacist-Biochemistry, graduated from USP. - MBA in Economy and Health Technology Assessment Fipe/FEA/USP. - Health Surveillance Management Specialist (IEP-HSL/Anvisa/MS). - Health Technology Assessment and Real-World Evidence Consultant - Team and Project management. - Comprehension of the National and International Health Regulation - Strong background in pharmacovigilance, Pharmacoepidemiology and Pharmacoecomy. - Understanding of Public Health Policies and Pharmaceutical Market. - Specialist in Biologic, Biosimilar, Advanced Therapies and Rare Diseases. - Training of professionals for Pharmacovigilance, Pharmacoepidemiology, Pharmacoeconimics, Regulatory Affairs and Public Brazilian Health System. - Executive Member of the Pharmacology Committee (Health Department of SP) for Health Technology Assessment (HTA). - Member of the Pharmacovigilance Technical Board/Anvisa. - International Technical Cooperation in Sanitary Surveillance/Pharmacovigilance - Pharmacovigilance, Pharmacoepidemiology, Pharmacoeconomic and Regulatory Affairs classes as a post-graduated professor. - Invited to become reviewer of the Journal "Value in Health Regional Issues" and Consultant in Marketing Research involving HTA Specialties: Pharmacoeconomy, Pharmacoepidemilogy, Pharmacovigilance, Health Technology Assessment, Market Access, Pricing, Real-World Evidence, Biologics and Biosimilars Drugs, Health Surveillance and Postgraduated Professor.

Ask me about
Brachytherapy
National Health Surveillance Agency
National Committee for Health Technology Incorporation
Inter-ministerial Pharmaceutical Price Regulation Board (CMED)
Pharmacovigilance Technical Board/Anvisa
Health Technology Assessment (HTA)
Evaluation Process
Price Setting
Negotiation
Funding
Drug Reimbursement
Drug Strategy
Rare Diseases
Artificial Inteligence
Advanced Therapies
Price setting and negotiations
Funding or reimbursement decisions
Proton Beam Therapy (PBT)
Enucleation
Orphan Disease
Work experience

Oct 2020 - Present

ANVISA

SCMED/Anvisa - HTA Specialist Consultant (PAHO)

Technical Support to the CMED (Brazilian Drug Market Regulation Chamber) Executive Secretary to establish criteria for defining and adjusting drug prices. - Public Health - Pharmacoepidemiology - Health Economics/pharmacoeconomics - Health Technology Assessment (HTA) - Pricing

logo

Jun 2009 - Present

Faculdades Oswaldo Cruz

Posgraduation Professor

Professor of the Pharmacoepidemiology, Pharmacoeconomycs, Pharmacovigilance and Clinical Research modules in the Posgraduation courses in Clinical Pharmacology, Regulatory Affairs and Sanitary Surveillance.

Feb 2019 - Sep 2020

Heads in Health

Health Economy, Real-World Evidence and Market Access consultant

- Responsible for managing and executing Projects in Health Technology Assessment (HTA), Health Economic, Pricing, evidence generation and market access strategy for Pharma. - Management of the internal and external partners ensuring scientific rigor in build HTA Dossier (Systematic Review and Economic Studies) and RWE generation. - Support to create strategies involving artificial intelligence in Real World Data projects involving new drugs, Patient Finder Advanced Therapies and Rare Diseases. - Training in HEOR, RWE, Brazilian Health System and Pharmacovigilance. - Technical Support to Commercial Team.

Jul 2008 - Jan 2019

Health Surveillance Center at Sao Paulo State Government

Regional Director of Pharmacovigilance

- Implemented and managed at regional level all technical and regulatory aspects of pharmacovigilance of Health Surveillance Center - CVS SP - - Leadership of multidisciplinary team - Comprehension of the National and International Sanitary Regulation - Interaction with the Brazilians Health Surveillance Agency - Anvisa - Pharmaceutical Industries and Hospitals of the State of Sao Paulo, to facilitate of the national and international Pharmacovigilance flow. - Case Assessment. - Management of the on-line system Notification of adverse drug reactions. - Pharmacovigilance Inspections along National System of Sanitary Surveillance. -Training of Health Professionals and Health Services for Pharmacovigilance and Rational Use of Drugs through Conferences, Seminars and Workshops. -Technical meetings with Pharmacies, Hospitals and Pharmaceutical Industries, aiming at the risk management drugs and publications of sanitary rules. - Pharmacist preceptor at Pharmaceutical Education Program (PET - Saúde) - Executive Member of the Pharmacology´s Commission of SES-SP

Jul 2010 - Dec 2018

São Paulo Department Health/ São Paulo University/ Brazilian Health of Ministry

Pharmacist preceptor at Pharmaceutical Education Program (PET - Saúde)

Academic and scientific training program developed in partnership with the Brazilian Ministry of Health, Faculty of Pharmaceutical Sciences at USP and São Paulo Department of Health in order to educate and train undergraduates pharmacy students for Pharmacovigilance and Public Health.

May 2005 - Oct 2007

Secretaria Municipal da Saúde de São Paulo

Pharmacist Consultant - UNESCO -

- Deployment of pharmacovigilance activities in the Municipal Health Department of Sao Paulo. - Receiving and Causality assessment of adverse drug reactions reported by health professionals, using as research source International Database - Micromedex Health Care. - Studies of medicine use in patients admitted with diagnosis of acute infarction of myocardial in two general hospitals. Study had approval of the Ethics Committee. - Implantation of the pharmacovigilance program of controlled antibiotics, together the Commissions of Hospital Infection. - Pharmacovigilance Training for professionals in the Basic Health Units. - Participation with Anvisa to implement the national system of reporting of adverse drug events - Notivisa.

Education

2015 - 2016

Fipe

MBA, Economy and Health Technology Assessment

Monograph: Efficacy, Safety, and Costs of evolocumab and alirocumab used in the treatment of Heterozygous Familial Hypercholesterolemia from the SUS perspective.

Board Certified

Talk to Adalton

@ Copyright 2020 OfficeHours Technologies Co.